More than half a billion of EU investment to stop HIV, tuberculosis and malaria

More than half a billion of EU investment to stop HIV, tuberculosis and malaria


Commissioner for International Cooperation and Development, Neven Mimica, announced today a contribution of €550 million for the period 2020-2022 to support the work of the Global Fund to end the epidemics of HIV, tuberculosis and malaria worldwide. Commissioner Mimica made the announcement in Lyon where global leaders are gathering for the Fund’s pledging conference organised by French President, Emmanuel Macron. This follows the initial announcement made by Donald Tusk at the G7 Meeting one month ago.

Commissioner Mimica said, “Despite remarkable progress, HIV, tuberculosis and malaria are still threatening our societies, killing a child every two minutes and preventing us from achieving the Sustainable Development Goals.  The good news is that these epidemics can be ended. But we need to work better together at every level to build better quality and stronger health systems for all. This is why the EU has decided to step up the fight and pledge an EU contribution to the Fund of €550 million”.

The total pledge of €550 million represents a 15% increase on the previous EU pledge of €475 million for the period 2017-2019.  Thanks to similar increases in commitments from other key donors, the Global Fund is set to reach its ambitious target of $14 billion.



The European Union has been associated with the Global Fund ever since it was founded in 2002. The European Union is the sixth-largest donor to the Global Fund and since 2002 the EU has contributed more than €2 billion to the Fund. Global Fund also receives support from many EU Member States directly, bringing the contribution of the EU collectively to almost 50% of all resources received by the Global Fund.  

Thanks to the European Union the Global Fund partnership has had an extraordinary impact. In the countries in which the Global Fund invests, more than 27 million lives have been saved. The number of people dying from AIDS, TB and malaria has been slashed by one-third. In 2017 alone, Global Fund investments resulted in antiretroviral therapy for 17.5 million HIV sufferers, treatment for 5 million TB patients and the distribution of 197 million mosquito nets.

For the period 2020-2022, the Global Fund has set three new main objectives, in line with the EU’s priorities:

1) Reduce the 2017 mortality rate by 52% by 2023, saving 16 million people from the three diseases.

2) Avert 234 million infections or cases reducing the incidence rate by 42%  across the three diseases by 2023, relative to 2017 levels.

3) Reduce the death toll from the three diseases to 1.3 million by 2023 (down from 2.5 million in 2017, and from 4.1 million in 2005).